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Summary. Pediatric pleural empyema has increased substantially over the past 20 years and
reasons for this rise remain not fully explained. We investigated potential risk factors for the
development of empyema in children by examining a cohort of patients with community-acquired
pneumonia. Demographic, clinical, and socioeconomic characteristics, use of Ibuprofen prior to
presentation and selected potential epidemiological risk factors were analyzed. Data were
collected from a prospective etiological study of radiologically confirmed pneumonia in hospitalized
children aged16 years. One hundred sixty children were enrolled; 56%weremale and 69%aged
<5 years. Empyema complication developed in 40 (25%) children. Children with empyema were
more frequently prescribed Ibuprofen prior to admission to hospital than those without (82% vs.
46.2%; OR 1.94, 97.5% credible interval 0.80–3.18). Bacterial infection was strongly associated
with the development of empyema (OR 3.34, 97.5% credible interval 1.70–5.14). In contrast age,
sex, maternal age, parental smoking, level of socioeconomic status, nursery attendance, asthma,
household characteristics (bedrooms and number of occupants) were not significantly different
between groups. In conclusion, children with pneumonia who developed empyema hadmore often
received Ibuprofen prior to hospitalization and confirmed bacterial infection. We suggest a
population-based study involving both primary and secondary care settings would help to
investigate the role of Ibuprofen use in modulating the course of disease in children with
pneumonia. Pediatr Pulmonol. 2015;50:721–726.  2014 Wiley Periodicals, Inc.
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INTRODUCTION
The incidence of pediatric pleural empyema has
increased substantially over the past 20 years in
developed countries leading to considerable research
focus on this infection.1,2 Factors that might determine the
progression from uncomplicated community-acquired
pneumonia (CAP) to complicated pneumonia or empy-
ema remain uncertain.3 Previous retrospective studies
have suggested that children with empyema were older,
had been unwell longer and were likely to have received
antibiotics or Ibuprofen before presentation to hospital.4,5
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A significant association has also been found with
infection with varicella-zoster virus in the preceding
month of illness.5
Historically pleural infection has been difficult to study
because of lack of a suitable in vivo model.6 Recent
advances in this area are starting to elucidate potential
pathophysiological mechanisms.7 Wilkosz et al.7 de-
scribed evidence of early pleural invasion in murine
models of pleural infection even in the absence of
established pneumonia. Identifying putative epidemio-
logical risk factors thatmay contribute to the development
of empyema is important in establishing effective public
health interventions to reduce disease burden. We
therefore used a nested case-control analysis to explore
possible risk factors into the etiology of empyema among
hospitalized children with CAP.8
METHODS
Participants
A prospective etiological study of pneumonia was
conducted from October 2009 to March 2011.8 Eligible
children were aged16 years whowere hospitalized with
clinical and radiological features suggestive of pneumo-
nia. Children were from the North East of England
(excluding Cumbria) who presented or were transferred to
the pediatric services at both the Newcastle Hospitals and
South Tees Hospitals NHS Foundations Trusts. The
former site includes the regional cardiothoracic center
where empyema is managed. Informed written consent
was obtained from parents and assent from older children.
Ethical and Caldicott approvals were granted (Newcastle
and North Tyneside Research Ethics Committee [No: 08/
H0906/105], and Research Approval Board at South Tees
Hospitals NHS Trust [No: 2008075]).
Exclusion criteria included clinical diagnosis of
bronchiolitis, hospitalization in the preceding 3 weeks,
or normal chest radiograph after formal reporting by a
radiologist. In the UK, children are assessed by a General
Practitioner in primary care or accident and emergency
team and then referred to a hospital-based pediatrician if
secondary care is required.
Laboratory and Radiological Procedures and Case
Definition
Microbiological and virological testing informed the
etiology of pneumonia.8 Identified pathogens were catego-
rized as viral, bacterial, or mixed viral–bacterial infections
according to defined diagnostic criteria (Table 1).8
Chest radiographs were taken upon admission to
hospital and first reported by local radiologists then
reviewed by a second consultant cardiothoracic radiolo-
gist at the regional center. All involved reporters received
the same training in pediatric radiology and were either
pediatric radiologists or general radiologists who regu-
larly report chest radiographs for children. Radiographic
findings were categorized into lobar, patchy, or perihilar
according to WHO criteria.9
Empyema was clinically diagnosed and this was
coupled with evidence of loculated pleural fluid on
chest radiograph and/or chest ultrasound scan. Only those
cases that required invasivemanagement (pleural drainage
TABLE 1—Laboratory Investigations and Diagnostic Criteria of Likely Causative Pathogens of Pneumonia
Sample Pathogen/antigen Tests Interpretation
Serum Respiratory viruses Complement fixation Acute titer 1/128 or
fourfold rise between paired sera
Atypical bacteria
Mycoplasma IgM antibody Positive
Group A Streptococcus Antistreptolysin O titer (IU/ml) Acute twofold rise or
fourfold rise between paired sera
Blood Bacteria Culture Growth
Streptococcus pneumoniae Real-time PCR Positive
Nasopharyngeal
secretions/sputum
Respiratory viruses Real-time PCR Positive
Tracheobronchial
secretions (collected
via endotracheal tube or
bronchoalveolar lavage)
Respiratory viruses Real-time PCR Positive
Bacteria Culture/real-time PCR Growth/positive
Pleural fluids Bacteria Culture Growth
Pneumococcal antigen ELISA1 Positive
Streptococcus pneumoniae Real-time PCR Positive
1ELISA, enzyme-linked immunosorbent assay.
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and/or decortication) were included in the empyema
group. All empyema cases had grossly drained purulent
pleural fluid irrespective of the microbiological result.
Epidemiological Data
Possible determinants of CAP were selected based on
the previous literature.5,10,11 Data were collected on
demographic and socioeconomic characteristics, use of
Ibuprofen prior to presentation, and selected risk factors
such as asthma, parental smoking, and nursery atten-
dance. Pneumococcal immunization history was obtained
for each child from parents, and where available it was
cross-checked with the child’s parent held health records.
If there was uncertainty about the immunization history,
general practice surgeries were contacted and practice
records of vaccines given checked.
Parental occupation information was incomplete,
therefore socioeconomic status and the measure of
deprivation were derived for each child based on the
index of multiple deprivation (IMD) score for the parental
postcode of residence [The English Index of Deprivation
2007, Office for National Statistics (ONS)].12
Statistical Analysis
Values for missing data from the covariates were
estimated from the known data in order to prevent
interpretation bias. An advantage of this methodology is
the ability to account for missing covariate data. Rather
than discarding the cases, missing data can be simulated
either from the total known population, or using
information from known covariates to estimate based
upon other similar individuals.
Univariate analysis assessed the association between
possible risk factors and the development of empyema,
with the general model structure:
Yi  Bernoulli distributionðPiÞ
logit ðPiÞ < aþ bcovi
where Yi is the binary output for whether individual i has
empyema, Pi is the probability of empyema, a is the
intercept term, b is the regression coefficient, and covi is
the covariate value for individual i. The Bernoulli
distribution is a discrete probability distribution, which
takes value 1 with success probability P, and value 0 with
failure probability q, equal to q¼ 1P.
Data were analyzed using the R2jags package13 within
the R statistical software.14 JAGS is “Just Another Gibbs
Sampler.”15 It is a program for Bayesian models using
Markov Chain Monte Carlo (MCMC) methods. A 10,000
iteration “burn-in” was followed by a 50,000 iteration
sample; with model convergence assessed using the
Gelman–Rubin diagnostic.16 A model was assumed to
have converged if the Gelman–Rubin diagnostic was
below 1.1.17 All of our models comfortably satisfied this
requirement. A covariate was considered significant if
97.5% of its posterior distribution lay either above or
below zero.Multivariate analysis included those variables
identified as significant in the univariate analysis, using
the same tests for significance. Similar subgroup analysis
was conducted among only those children with lobar
pneumonia in order to investigate if the findings could be
replicated. When testing whether the type of infection is
significant predictor for the development of empyema,
mixed bacterial–viral infections were excluded from the
analysis to avoid potential bias to the findings.
RESULTS
A total of 225 children were initially enrolled; 65 were
excluded (60 had a normal chest radiograph, 5 lived
outside of the North East of England), leaving 160 eligible
for inclusion. Of these, 56%weremales and 69% aged<5
years. There were no deaths. Based on age criteria,
pneumococcal vaccination uptake among 119 eligible
children was 94% (89 had PCV7, 10 PCV13, and 13
received combinations of each; Table 2).
Lobar consolidation was reported in 61% of children,
perihilar in (21%) and patchy changes (18%). Pleural fluid
(including empyema) was noted in 68 (42.5%) children:
55 (80.9%) together with lobar changes, 10 (14.7%) with
patchy and 3 (4.4%) with perihilar. Empyema occurred in
40 (25%) children; with 36 lobar, 3 patchy, and 1 perihilar
changes. There were no significant differences in age
(P¼ 0.650) and sex (P¼ 0.091) between children with
empyema and those with pneumonia only.
The etiological characteristics of pneumonia and
pneumococcal serotype distribution of this cohort have
TABLE 2—Number of Received Doses of the Pneumococcal
Conjugate Vaccine (PCV)
Received doses of PCV
Pneumonia
without empyema
Pneumonia
with empyema
n n
PCV7 (n¼ 67)1 (n¼ 22)2
1 dose 11 2
2 doses 15 4
3 doses 41 16
PCV13 (n¼ 10)2 (n¼ 0)
1 dose 4 —
2 doses 5 —
3 doses 1 —
Both PCV7 and PCV13 (n¼ 10) (n¼ 3)
1 dose of each 1 —
2 PCV7þ 1 PCV13 doses 9 2
1 PCV7þ 2 PCV13 doses — 1
1Five children had partial schedule with one dose less for their age.
2One child had one dose less for age.
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been presented previously.8 A likely causative pathogen
was established in 61% of children; 31% viral, 17.5%
bacterial, and 12.5% mixed infections. Pneumococcal
infections accounted for 17.4% of children tested (14/93
[15%] and 10/45 [22.2%] in those aged under and over
5 years, respectively). Among those 40 children who
developed empyema the causative bacterial pathogen was
identified in 75%; 20 (66.7%) Streptococcus pneumoniae
[serotypes 1 (n¼ 7), 3 (n¼ 5), 19A (n¼ 4), 7A/F (n¼ 1),
non-typeable (n¼ 2) and one serotype was not processed
for typing], 7 (23.3%) group A streptococcus, 2 (6.7%)
Staphylococcus aureus, and 1 (3.3%) Streptococcus
intermedius. Pneumococcal infection was identified in
four children with pneumonia only; one serotype 1, one
non-typeable serotype, and two were not processed for
typing.
Table 3 summarizes the univariate and multivariate
analyses. Children with empyema were more frequently
prescribed Ibuprofen prior to admission to hospital than
thosewho did not develop empyema (82%vs. 46.2%) (OR
1.94, 97.5% credible interval 0.80–3.18) and bacterial
infection was strongly associated with the development
of empyema (OR 3.34, 97.5% credible interval 1.70–
5.14). In contrast age, sex,maternal age, parental smoking,
level of socioeconomic status, nursery attendance, asthma,
household characteristics (bedrooms and number of
occupants) were not significantly different between
groups. These findings were consistent in the subgroup
analysis of only children with lobar pneumonia. Addition-
ally, among children with lobar changes only, empyema
occurred more often in boys than girls compared to those
with pneumonia only (OR 5.07, 97.5% credible interval
0.80–19.58).
DISCUSSION
The present study demonstrated that children with
pneumonia who developed empyema had more often
received Ibuprofen prior to hospitalization and were more
likely to have suffered proven bacterial infection. These
findings were replicated when analyses included only
children with lobar chest radiographic changes and are of
potential importance to public health policymakers for
disease prevention at the community level.
Our findings are broadly consistent with previous data.
Byington et al.5 found in a retrospective study empyema
was associated with older age >3 years, recent varicella
infection, pneumococcal infection with serotype 1, longer
febrile illness and likely to receive antibiotics, and
Ibuprofen before hospitalization.5 In England and Wales
non-PCV7 serotypes are now associated with invasive
pneumococcal disease18 and an increase in pneumococcal
serotype 19A is associated with complicated pneumonia
with empyema.19 Francois et al.4 found that suppurative
complications of pneumonia were associated with older
age, longer illness duration and frequently received
antibiotics, and Ibuprofen prior presentation to hospital.
However, of these, only use Ibuprofen was significant.4
Ibuprofen was also found to be significantly associated
with the occurrence of necrotizing fasciitis particularly
TABLE 3—Analysis of Possible Risk Factors Associated With the Development of Empyema in Children With Pneumonia
Characteristics
Pneumonia without
empyema (n¼ 120)
Pneumonia with
empyema (n¼ 40)
Missing
data, n
Univariate
analysis
Multivariate
analysis
N/total (%) N/total (%)
OR (97.5%
credible interval)
OR (97.5%
credible interval)
Male sex 62 (51.7) 28 (70) 0 2.41 (1.05–4.89) 0.89 (0.26–2.06)
Age (years)1 2.3 (4.0 4.02) 3.6 (5.6 4.65) 0 1.09 (1.00–1.18) 0.05 (0.18–0.09)
Under five 87 (72.5) 24 (60) — —
Under two 53 (44) 8 (20) — —
Socioeconomic status
(IMD score)1
28.5 (33.8 23.34) 30.8 (32.1 20.71) 0 1.00 (0.98–1.01) —
Classification of infection
(viral/bacterial)2
47 (39.2)/10 (8.3) 2 (5.0)/18 (45.0) 83 54.25 (6.74–233.00) 3.34 (1.70–5.14)
Nursery attendance for
preschool age group
31/79 (39.2) 12/24 (50) 0 2.09 (0.83–4.50) —
Asthma 10 (8.3) 2 (5) 0 0.66 (0.07–2.11) —
Maternal age (years)1 32 (32.4 6.96) 34 (33.5 7.36) 12 1.02 (0.97–1.08) —
Parental smoking 42/105 (40) 14/37 (37.9) 18 0.99 (0.42–2.00) —
Bedrooms in residence1 3.5 (3.1 0.81) 3.5 (3.1 0.96) 23 1.05 (0.64–1.61) —
Members of household1 4.0 (4.1 1.32) 4.5 (3.9 1.23) 14 0.86 (0.64–1.15) —
Preadmission Ibuprofen usage 55/119 (46.2) 32/39 (82) 2 6.36 (2.36–15.00) 1.94 (0.80–3.18)
OR, odds ratio; IMD, index of multiple deprivation.
1Values are expressed as median (mean standard deviation).
2Twenty mixed viral–bacterial infections were excluded from analysis and together with unknown a etiology added to the missing data.
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that caused by group A streptococcal infection.20,21
Several explanations have been suggested for these
findings, ranging from a simple association to more
complex pathophysiological hypotheses.
It seems plausible that perhaps the increased Ibuprofen
risk may simply reflect the fact that these patients were
unwell, had a higher fever and in more discomfort thus
were more likely to need antipyretics or analgesics and
therefore increasing the odds of receiving Ibuprofen.
However, recent fever may play an important regulatory
role in the control of infection and Ibuprofen usage in this
context may be immunomodulatory.Many pneumococcal
serotypes are temperature-sensitive, with thermal death
points between 40 and 418C.22,23 The presence of fever
enhances immunological responses resulting in the
reduction of replication of viruses and bacteria and
effective suppression of fever may interfere with these
responses.24 This is suggested clinically by Prymula
et al.25 who compared fever, local pain responses, and
post-vaccination specific-antibody levels between chil-
dren given PCV10 and randomized into two groups of
either Paracetamol prophylaxis for the first 24 hr or not.
Fever>388C was less common in the prophylactic group
after both the primary and booster vaccinations, with
associated significantly lower pneumococcal antibody
responses.25
It was surprising that parental smoking was not a risk
factor for empyema/severe complicated pneumonia,
given that there was a relative excess of smoking in the
studied cohort (40%) compared to the national average
rate of 21% for adults.26 Pooled review data showed that
household smoking is a significant risk factor of lower
respiratory tract infections and asthma in children.27–29
Self-reporting of parental smoking is usually under-
estimated.30,31 As the present study collected information
on parental smoking based on self-reporting this may
have biased the analysis of smoking as a predictor of
empyema. It has been suggested that measuring cotinine
levels in blood and urine of children could overcome
under reporting of passive smoking.30,31 Similarly, self or
parental reporting of asthma may be compromised due to
the variability of defining asthma in children.32,33
Strengths and Limitations
The strengths of this study include the prospective
design evaluating the risk factors for development of
empyema in a defined cohort with radiologically classified
pneumonia using robust diagnostic etiological investiga-
tions.8 It is limited by the fact that association of the
significantly identified risk factors does not imply causal
relationship. Therefore the interpretation of these findings
should be guarded. Further limitation is that no details on
the frequency and doses of Ibuprofen and timing of its use
in relation to the start of the illness. This information was
deemed difficult to ascertain because of over the counter
self-prescription.
Another limitation is the risk of circularity because of
the methods of pathogen detection. Rates of specific
pathogen detection are low in children with pneumonia
and in our cohort molecular testing of pleural fluid
provided a definitive diagnosis of bacterial infection in a
high proportion. This may reflect the fact that these
childrenwere genuinely at higher risk because of bacterial
infection but may be a reflection of ascertainment bias.
Our interpretation is that this is a genuine increased risk
but without adopting alternative diagnostic methods into
routine practice for children with pneumonia it is
impossible to be certain.
In conclusion, pre-hospital administration of Ibupro-
fen, and confirmed bacterial infection were associated
with increased risk of empyema during hospital admis-
sion of childrenwith pneumonia.We suggest a large-scale
population-based study involving both primary and
secondary care settings would help to investigate the
role of Ibuprofen use in modulating the course of disease
in children with pneumonia.
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